Marshall Urist
EVP, Research & Investments · 3 filings · Latest: May 20, 2026
Royalty Pharma plc
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
RPRX | Marshall Urist | EVP, Research & Investments | May 20, 2026 | Sale | $52.75 | 13,684 | $721.8K | 18,197 | |
RPRX | Marshall Urist | EVP, Research & Investments | May 14, 2026 | Sale | $53.06 | 13,684 | $726.1K | 31,881 | |
RPRX | Marshall Urist | EVP, Research & Investments | May 6, 2026 | Grant/Award | $0.00 | 18,197 | — | 45,565 |